Houston Health Department


HAI Reporting



HAI Reporting

In the fall of 2016, CDC launched the Antibiotic Resistance Laboratory Network, or ARLN. The ARLN is a comprehensive laboratory capacity network working to improve testing capacity for antimicrobial-resistant and difficult to treat pathogens. As part of this initiative, the Houston Health Department was funded to accept isolates, confirm and characterize the mechanisms of resistance for Carbapenem Resistant Enterobacteriaceae (CRE) and Carbapenem-Resistant Pseudomonas aeruginosa (CRPa). For more information on this program, please see the following: